Metraipolis › archive › dc_25c82130daaa

Neurotransmitter Dysregulation in Parkinson's Disease: Pathophysiological Insights and Therapeutic Perspectives — Europe PMC PMID:41904982

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41904982
DOI
10.1021/acschemneuro.5c00809
License (as archived)
solo-consultazione
Archived
2026-11-03T17:29:28.007Z
SHA-256 of the archived text
3ccbd766f84e63a20b835c3f5e09eb854e791bb370632f7614d567ed75581968
Stable URL of this page
https://metraipolis.com/documento/dc_25c82130daaa

How to cite

Neurotransmitter Dysregulation in Parkinson's Disease: Pathophysiological Insights and Therapeutic Perspectives — Europe PMC PMID:41904982 — Europe PMC (en), https://europepmc.org/article/MED/41904982 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_25c82130daaa (Metraipolis archive dc_25c82130daaa, sha256 3ccbd766f84e63a20b835c3f5e09eb854e791bb370632f7614d567ed75581968)
BibTeX
@misc{dc25c82130daaa,
  title = {Neurotransmitter Dysregulation in Parkinson's Disease: Pathophysiological Insights and Therapeutic Perspectives — Europe PMC PMID:41904982},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41904982},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_25c82130daaa; sha256 3ccbd766f84e63a20b835c3f5e09eb854e791bb370632f7614d567ed75581968},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41904982. Agents can read the archived copy with the MCP tool read_document.